Loading...
Market
Which company will first develop a commercial genetic test for COVID-19 susceptibility based on the USP gene discovery by December 31, 2025?
2
Resolution / Starting Odds
23andMe • 25%
AncestryDNA • 25%
MyHeritage • 25%
Other company • 25%
Announcements from biotechnology companies or regulatory approvals
Story
University of São Paulo Researchers Identify Gene That May Protect Against COVID-19
Dec 2, 2024, 03:12 PM
Brazilian researchers have identified a gene that may provide protection against COVID-19. This significant discovery was made by scientists at the University of São Paulo (USP) and has been reported by various media outlets. The findings suggest that this genetic variation could play a crucial role in enhancing immunity to the virus, potentially leading to new therapeutic approaches in combating COVID-19. The research adds to the growing body of knowledge regarding genetic factors influencing susceptibility to the virus, which remains a global health concern.
View original story
Similar markets
Pfizer • 25%
Roche • 25%
Novartis • 25%
Other • 25%
Illumina • 25%
Thermo Fisher Scientific • 25%
Bio-Rad Laboratories • 25%
Other • 25%
Illumina • 25%
Thermo Fisher Scientific • 25%
Pacific Biosciences • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
AstraZeneca • 25%
Other • 25%
Roche • 25%
Abbott • 25%
Thermo Fisher • 25%
Other • 25%
Editas Medicine • 25%
Intellia Therapeutics • 25%
CRISPR Therapeutics • 25%
Other • 25%
Positive results for Shield • 25%
Positive results for Reveal • 25%
Positive results for Guardant360 • 25%
No positive results • 25%
Cancer Research • 25%
Neurological Disorders • 25%
Genetic Disorders • 25%
Other • 25%
Illumina • 25%
Thermo Fisher • 25%
Roche • 25%
Other • 25%
Manufacturer A has largest share • 25%
Manufacturer B has largest share • 25%
Manufacturer C has largest share • 25%
Manufacturer D or others have largest share • 25%